Hi, ruff
I , too, think that OBJ is worth more than its current market cap indicates. But without any revenue/earning, the market cap of obj will be mostly influenced by market sentiment, imo.
I also see the risky side of OBJ business from a shareholder’s view: For example:
1 what if 2007 is sort of repeat of 2006: announcements on progress of OBJ tech, talks of discussion with pharma, no revenue, no deal and another share placement?
2. In the annual report, it mentioned Cosmetic/ Life Style Delivery Systems (OBJ wearable watch patch). My interpretation is that OBJ will want to start the production of the patches, which I perceive as a negative. Why so? Because I perceive OBJ board as mostly a science team. Do they have the capacity to actually mange a successful manufacture business? Do they have the necessary facilities? (such as marketing, sales distribution, etc) to actually sell the patches successfully? I doubt it. The team does scientific work best. So I would like to think that doing more tests / trials and licensing its technology is the way to go. Not wise to get involved in the production business.
The above is just my personal opinion.
A pharma deal to license OBJ’s technology that brings royalties will be really good to the company and its shareholders.
Please do your own research
- Forums
- ASX - By Stock
- not long now
Hi, ruffI , too, think that OBJ is worth more than its current...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable